Sara E. Stevens

736 total citations
7 papers, 226 citations indexed

About

Sara E. Stevens is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sara E. Stevens has authored 7 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sara E. Stevens's work include Lung Cancer Treatments and Mutations (6 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer Research and Treatments (1 paper). Sara E. Stevens is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer Research and Treatments (1 paper). Sara E. Stevens collaborates with scholars based in United States and Australia. Sara E. Stevens's co-authors include Lecia V. Sequist, Alice T. Shaw, Justin F. Gainor, Jeffrey A. Engelman, Ibiayi Dagogo‐Jack, W. Marston Linehan, Jochen K. Lennerz, Subba R. Digumarthy, Matthew J. Niederst and Elizabeth A. Kennedy and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology and PubMed.

In The Last Decade

Sara E. Stevens

7 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara E. Stevens United States	7	168	116	80	50	29	7	226
Stephanie P.L. Saw Singapore	6	166 1.0×	138 1.2×	68 0.8×	54 1.1×	32 1.1×	14	278
Eisuke Kurihara Japan	8	113 0.7×	148 1.3×	110 1.4×	48 1.0×	17 0.6×	12	271
Silvana Acquafredda Italy	6	94 0.6×	159 1.4×	42 0.5×	40 0.8×	19 0.7×	8	237
B.C. Cho South Korea	8	232 1.4×	204 1.8×	90 1.1×	47 0.9×	16 0.6×	33	280
Giulia Grizzi Italy	12	185 1.1×	262 2.3×	82 1.0×	70 1.4×	15 0.5×	24	370
Christina J. Falcon United States	11	215 1.3×	183 1.6×	98 1.2×	64 1.3×	10 0.3×	22	304
David Vicente Baz Spain	10	138 0.8×	173 1.5×	52 0.7×	29 0.6×	20 0.7×	27	235
Thomas Göhler Germany	10	67 0.4×	132 1.1×	39 0.5×	56 1.1×	19 0.7×	34	225
Patricia Martín-Romano France	9	102 0.6×	195 1.7×	114 1.4×	55 1.1×	36 1.2×	29	306
Ilze Bāra United States	9	225 1.3×	260 2.2×	57 0.7×	38 0.8×	18 0.6×	22	365

Countries citing papers authored by Sara E. Stevens

Since Specialization

Citations

This map shows the geographic impact of Sara E. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Stevens more than expected).

Fields of papers citing papers by Sara E. Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara E. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Stevens. The network helps show where Sara E. Stevens may publish in the future.

Co-authorship network of co-authors of Sara E. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Sara E. Stevens. A scholar is included among the top collaborators of Sara E. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara E. Stevens. Sara E. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Dagogo‐Jack, Ibiayi, Philicia Moonsamy, Justin F. Gainor, et al.. (2021). A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor. Journal of Thoracic Oncology. 16(5). 850–859. 40 indexed citations

Piotrowska, Zofia, Stephen V. Liu, Alona Muzikansky, et al.. (2018). Safety of osimertinib plus chemotherapy in EGFR-mutant NSCLC.. Journal of Clinical Oncology. 36(15_suppl). e21231–e21231. 10 indexed citations

Linehan, W. Marston, Elizabeth A. Kennedy, Lecia V. Sequist, et al.. (2016). Clinical Activity of Alectinib in Advanced RET -Rearranged Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 11(11). 2027–2032. 75 indexed citations

Gainor, Justin F., Matthew J. Niederst, Jochen K. Lennerz, et al.. (2016). Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR -Mutant Lung Cancer Harboring De Novo MET Amplification. Journal of Thoracic Oncology. 11(7). e83–e85. 55 indexed citations

Dagogo‐Jack, Ibiayi, Justin F. Gainor, Rebecca L. Porter, et al.. (2016). Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping. Journal of Thoracic Oncology. 11(9). 1522–1528. 17 indexed citations

Griffin, Thomas W., A.B. Brill, Sara E. Stevens, et al.. (1991). Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.. Journal of Clinical Oncology. 9(4). 631–640. 16 indexed citations

Hnatowich, D.J., Mary Rusckowski, A.B. Brill, et al.. (1990). Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.. PubMed. 50(22). 7272–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact